Medtronic (MDT) Tops Q4 EPS by 3c, Offers FY19 Guidance

Medtronic (NYSE: MDT) reported Q4 EPS of $1.42, $0.03 better than the analyst estimate of $1.39. Revenue for the quarter came in at $8.1 billion versus the consensus estimate of $8 billion.

GUIDANCE:

Medtronic sees FY2019 EPS of $5.10-$5.15, versus the consensus of $5.15.

In fiscal year 2019, the company expects organic revenue growth to be in the range of 4.0 to 4.5 percent.

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Evercore lifts Ciena rating on AI-driven optical networking boom
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk